Abstract:Introduction: Cancer combination treatments involving immunotherapies with targeted radiation therapy are at the forefront of treating cancers. However, dosing and scheduling of these therapies pose a challenge. Mathematical models provide a unique way of optimizing these therapies. Methods: Using a preclinical model of multiple myeloma as an example, we demonstrate the capability of a mathematical model to combine these therapies to achieve maximum response, defined as delay in tumor growth. Data from mice studies with targeted radionuclide therapy (TRT) and chimeric antigen receptor (CAR)-T cell monotherapies and combinations with different intervals between them was used to calibrate mathematical model parameters. The dependence of progression-free survival (PFS), overall survival (OS), and the time to minimum tumor burden on dosing and scheduling was evaluated. Different dosing and scheduling schemes were evaluated to maximize the PFS and optimize timings of TRT and CAR-T cell therapies. Results: Therapy intervals that were too close or too far apart are shown to be detrimental to the therapeutic efficacy, as TRT too close to CAR-T cell therapy results in radiation related CAR-T cell killing while the therapies being too far apart result in tumor regrowth, negatively impacting tumor control and survival. We show that splitting a dose of TRT or CAR-T cells when administered in combination is advantageous only if the first therapy delivered can produce a significant benefit as a monotherapy. Discussion: Mathematical models are crucial tools for optimizing the delivery of cancer combination therapy regimens with application along the lines of achieving cure, maximizing survival or minimizing toxicity.

Optimal dosage protocols for mathematical models of synergy of chemo- and immunotherapy

A mathematical model of tumor-immune interactions incorporated with danger model

The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity

Modeling the dynamics of mixed immunotherapy and chemotherapy for the treatment of immunogenic tumor

An Optimal Control Strategy for Mathematically Modeling Cancer Combination Therapy

A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach

A Mathematical Model of Tumor‐Immune and Host Cells Interactions with Chemotherapy and Optimal Control

Mathematical Modeling of the Synergetic Effect between Radiotherapy and Immunotherapy

A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia

Different Strategies for Cancer Treatment: Mathematical Modeling

Optimization of chemotherapy regimens using mathematical programming

A biomathematical model of tumor response to radioimmunotherapy with $α$PDL1 and $α$CTLA4

Mathematical modeling as a tool for planning anticancer therapy

Addressing current challenges in cancer immunotherapy with mathematical and computational modeling

On a Mathematical Model Arising from an Optimal Chemotherapeutic Drug Treatment for Tumor Cells

Modeling Combination Chemo-Immunotherapy for Heterogeneous Tumors

Parameter estimation and treatment optimization in a stochastic model for immunotherapy of cancer

Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy

Combination therapies and intra-tumoral competition: Insights from mathematical modeling

Mathematical Modeling and Analysis of Tumor Chemotherapy

Mathematical modeling of combined therapies for treating tumor drug resistance